Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

• Main Authors: Haleh Rezaee (Author), Fariba Pourkarim (Author), Samira Pourtaghi‐Anvarian (Author), Taher Entezari‐Maleki (Author), Touraj Asvadi‐Kermani (Author), Masoud Nouri‐Vaskeh (Author)
• Format: Book
• Published: Wiley, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e., chloroquine, lopinavir/ritonavir, ribavirin, tociliz...